Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON44468
NL-OMON44468
Completed
Phase 2

on invasive imaging of tumor hypoxia with [18F]HX4 Positron-Emission-Tomography (PET): A phase II trial - HX4 several disease

MAASTRO Clinic0 sites120 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionshersenen, primaire maligne glioom of metastasencancer: several diseases1001799010038597

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
hersenen, primaire maligne glioom of metastasen
Sponsor
MAASTRO Clinic
Enrollment
120
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • •In order to be eligible to participate in this study, a subject must meet the general and tumor site specific criteria:;General:
  • •\- Histological/cytological confirmed carcinoma of de esophagus, rectum or prostate or
  • •radiological suspicion for Grade IV glioma (primary brain tumor) or brain metastases.
  • •\- WHO performance status 0 to 2\.
  • •\- Adequate renal function (calculated creatinine clearance at least 60 ml/min).
  • •\- The patient is willing and capable to comply with study procedures
  • •\- 18 years or older
  • •\- Have given written informed consent before patient registration;Prostate
  • •\- Histological confirmed prostate tumor
  • •\- High grade tumor (Gleason score \*8\)

Exclusion Criteria

  • •\- Recent (\< 3 months) myocardial infarction;\- Pregnant or breast feeding and willing to take adequate contraceptive measures during the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Imaging of tumor hypoxia with [18F]HX4 PET
EUCTR2014-003873-41-NLMAASTRO Clinic100
Not yet recruiting
Phase 2
Validation of hypoxia imaging of cancer in the head and neck area with FAZA-PET
NL-OMON32369Antoni van Leeuwenhoek Ziekenhuis20
Completed
Not Applicable
PET With [18F]HX4 in Head and Neck CancerCancer of the Head and Neck
NCT01347281Maastricht Radiation Oncology23
Terminated
Phase 2
PET CT With HX4 in Cervix CancerCervix Cancer
NCT02233387Maastricht Radiation Oncology4
Terminated
Phase 2
Tumor Hypoxia With HX4 PET in Several DiseasesProstatic NeoplasmsEsophageal NeoplasmsNeoplasm Metastases, BrainRectal NeoplasmsBrain Neoplasm, Primary
NCT02584400Maastricht Radiation Oncology1